Advisors Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Advisors Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,029	Closed	-$1.41M	–	1534
2021 Q3	$1.41M	Buy	70,029 +22,425	+47%	+$619K	0.02%	709
2021 Q2	$1.78M	Buy	47,604 +38,384	+416%	+$1.18M	0.03%	633
2021 Q1	$236K	Sell	9,220 -233	-2%	-$5.95K	﹤0.01%	1182
2020 Q4	$208K	Buy	9,453 +694	+8%	+$15.3K	﹤0.01%	1213
2020 Q3	$158K	Buy	8,759 +4,057	+86%	+$84K	﹤0.01%	1232
2020 Q2	$119K	Buy	+4,702	New	+$101K	﹤0.01%	1267

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Advisors Asset Management's DRNA Position: Q4 2021 in Review

Advisors Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 70,029 shares — an estimated $1.41M sold.

Advisors Asset Management first reported a position in DRNA in Q2 2020 and held it in 6 quarters. The position peaked at $1.78M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Advisors Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Advisors Asset Management sold 70,029 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.41M.
Advisors Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2020 and held it in 6 quarters.
Advisors Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $1.78M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Advisors Asset Management's 13F filing for Q4 2021, filed 15 Feb 2022.